Echo Therapeutics (ECTE) Reports Q3 Loss of $0.16/Share

November 16, 2015 4:42 PM EST

Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.16), versus ($0.21) reported last year.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings